Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195781 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-12 | 2023-11-23 | 198391 |
| TEVA-CINACALCET | 60MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-13 | 224910 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-05-03 | 2024-06-07 | 226945 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2024-06-13 | 227495 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2017-08-21 | 2017-10-10 | 19964 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-02-02 | 2023-04-28 | 183401 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-03 | 195766 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-03-21 | 2024-03-21 | 222952 |
| RATIO-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 226933 |
| RATIO-LACTULOSE | 667MG/ML | BOTTLE | Resolved | 2017-03-14 | 2017-12-15 | 2400 |
| TEVA-BROMAZEPAM | 6MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107952 |
| TEVA-BROMAZEPAM | 6MG | TABLET | Resolved | 2020-09-11 | 2020-10-15 | 124113 |
| CALMYLIN ACE | 7.5MG 10MG 100MG | SYRUP | Resolved | 2019-06-27 | 2019-08-06 | 87656 |
| TEVA-AMPHETAMINE XR | 7.5MG 7.5MG 7.5MG 7.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61333 |
| ACT MELOXICAM | 7.5MG | TABLET | Actual shortage | 2020-01-09 | 2020-01-09 | 102935 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-14 | 113013 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116669 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2020-09-11 | 2022-12-15 | 124110 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |